Compare IMNN & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNN | ABTS |
|---|---|---|
| Founded | 1982 | 2010 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0M | 7.4M |
| IPO Year | 2000 | 2021 |
| Metric | IMNN | ABTS |
|---|---|---|
| Price | $2.77 | $1.68 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $182.61 | N/A |
| AVG Volume (30 Days) | ★ 56.7K | 17.9K |
| Earning Date | 05-11-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.37 | $1.35 |
| 52 Week High | $9.32 | $10.86 |
| Indicator | IMNN | ABTS |
|---|---|---|
| Relative Strength Index (RSI) | 39.45 | 27.09 |
| Support Level | $0.48 | N/A |
| Resistance Level | $3.16 | $3.00 |
| Average True Range (ATR) | 0.23 | 0.27 |
| MACD | -0.02 | -0.06 |
| Stochastic Oscillator | 43.84 | 0.00 |
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.